TCG Crossover Management, LLC Diversified Active

CIK: 0001839948 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $249,097 (100.0% shares, 0.0% debt)

Holdings (20)

— Iveric Bio, Inc. 17.0%

Value ($000) $42,360 Shares 2,516,920 Est. Cost $16.75 Unrealized —

VRDN Viridian Therapeutics Inc 9.8%

Value ($000) $24,296 Shares 1,314,000 Est. Cost $18.63 Unrealized +3.2%

COGT Cogent Biosciences, Inc. 9.0%

Value ($000) $22,328 Shares 2,981,042 Est. Cost $8.56 Unrealized -18.6%

ACRS Aclaris Therapeuitics, Inc. 7.9%

Value ($000) $19,739 Shares 1,144,939 Est. Cost $15.07 Unrealized -9.5%

GERN Geron Corporation 7.8%

Value ($000) $19,429 Shares 14,285,715 Est. Cost $1.11 Unrealized 0.0%

— CymaBay Therapeutics, Inc. 7.4%

Value ($000) $18,366 Shares 5,905,400 Est. Cost $3.38 Unrealized —

— Aerovate Therapeutics, Inc. 6.5%

Value ($000) $16,306 Shares 889,572 Est. Cost $12.06 Unrealized —

— Chinook Therapeutics, Inc. 5.8%

Value ($000) $14,435 Shares 882,353 Est. Cost $16.31 Unrealized —

TYRA Tyra Biosciences, Inc. 3.9%

Value ($000) $9,592 Shares 896,418 Est. Cost $19.46 Unrealized -39.0%

TNGX Tango Therapeutics, Inc. 3.8%

Value ($000) $9,509 Shares 1,254,500 Est. Cost $8.67 Unrealized 0.0%

— Alpine Immune Sciences, Inc. 3.7%

Value ($000) $9,277 Shares 1,034,222 Est. Cost $13.85 Unrealized —

KURA Kura Oncology, Inc. 3.3%

Value ($000) $8,143 Shares 506,423 Est. Cost $14.44 Unrealized 0.0%

— Merus N.V. 3.2%

Value ($000) $7,932 Shares 300,000 Est. Cost $30.46 Unrealized —

— Akouos, Inc. 2.6%

Value ($000) $6,413 Shares 1,350,006 Est. Cost $7.65 Unrealized —

— Magenta Therapeutics, Inc. 2.5%

Value ($000) $6,160 Shares 2,124,122 Est. Cost $4.43 Unrealized —

TRDA Entrada Therapeutics, Inc. 2.5%

Value ($000) $6,133 Shares 663,694 Est. Cost $17.12 Unrealized —

ZLAB Zai Lab LTD-ADR 1.7%

Value ($000) $4,178 Shares 95,000 Est. Cost $62.85 Unrealized —

— Pardes Biosciences, Inc. 0.7%

Value ($000) $1,654 Shares 229,100 Est. Cost $7.22 Unrealized —

ANAB AnaptysBio, Inc. 0.6%

Value ($000) $1,448 Shares 58,515 Est. Cost $30.26 Unrealized 0.0%

— Elevation Oncology, Inc. 0.6%

Value ($000) $1,399 Shares 555,000 Est. Cost $6.02 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Iveric Bio, Inc.	2,516,920	$42,360	17.0%	$16.75	—	COMMON STOCK	46583P102
VRDN	Viridian Therapeutics Inc	1,314,000	$24,296	9.8%	$18.63	+3.2%	COMMON STOCK	92790C104
COGT	Cogent Biosciences, Inc.	2,981,042	$22,328	9.0%	$8.56	-18.6%	COMMON STOCK	19240Q201
ACRS	Aclaris Therapeuitics, Inc.	1,144,939	$19,739	7.9%	$15.07	-9.5%	COMMON STOCK	00461U105
GERN	Geron Corporation	14,285,715	$19,429	7.8%	$1.11	0.0%	COMMON STOCK	374163103
—	CymaBay Therapeutics, Inc.	5,905,400	$18,366	7.4%	$3.38	—	COMMON STOCK	23257D103
—	Aerovate Therapeutics, Inc.	889,572	$16,306	6.5%	$12.06	—	COMMON STOCK	008064107
—	Chinook Therapeutics, Inc.	882,353	$14,435	5.8%	$16.31	—	COMMON STOCK	16961L106
TYRA	Tyra Biosciences, Inc.	896,418	$9,592	3.9%	$19.46	-39.0%	COMMON STOCK	90240B106
TNGX	Tango Therapeutics, Inc.	1,254,500	$9,509	3.8%	$8.67	0.0%	COMMON STOCK	87583X109
—	Alpine Immune Sciences, Inc.	1,034,222	$9,277	3.7%	$13.85	—	COMMON STOCK	02083G100
KURA	Kura Oncology, Inc.	506,423	$8,143	3.3%	$14.44	0.0%	COMMON STOCK	50127T109
—	Merus N.V.	300,000	$7,932	3.2%	$30.46	—	COMMON STOCK	N5749R100
—	Akouos, Inc.	1,350,006	$6,413	2.6%	$7.65	—	COMMON STOCK	00973J101
—	Magenta Therapeutics, Inc.	2,124,122	$6,160	2.5%	$4.43	—	COMMON STOCK	55910K108
TRDA	Entrada Therapeutics, Inc.	663,694	$6,133	2.5%	$17.12	—	COMMON STOCK	29384C108
ZLAB	Zai Lab LTD-ADR	95,000	$4,178	1.7%	$62.85	—	COMMON STOCK	98887Q104
—	Pardes Biosciences, Inc.	229,100	$1,654	0.7%	$7.22	—	COMMON STOCK	69945Q105
ANAB	AnaptysBio, Inc.	58,515	$1,448	0.6%	$30.26	0.0%	COMMON STOCK	032724106
—	Elevation Oncology, Inc.	555,000	$1,399	0.6%	$6.02	—	COMMON STOCK	28623U101